531015 VENMAX

Venmax Drugs & Pharmaceuticals Share Price

₹13.49 +1.22 (9.94%)

23 Dec, 2024 04:23

SIP TrendupStart SIP in VENMAX

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 222.73%
  • Over 3 Month + 222.73%
  • Over 6 Month + 222.73%
  • Over 1 Year + 222.73%
SIP Lightning

Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Venmax Drugs & Pharmaceuticals Financials

Venmax Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹13.49
+ 1.22 (9.94%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹8.31
  • 50 Day
  • ₹5.96
  • 100 Day
  • ₹4.74
  • 200 Day
  • ₹4.41

Resistance and Support

13.49 Pivot Speed
  • R3 13.49
  • R2 13.49
  • R1 13.49
  • S1 13.49
  • S2 13.49
  • S3 13.49

What's your outlook on Venmax Drugs & Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

N/A

Group Rank

Venmax Dg.And Pharms. has an operating revenue of Rs. 0.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -9% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-12 Quarterly Results
2024-05-14 Audited Results
2024-01-30 Quarterly Results
2023-11-14 Quarterly Results

Venmax Drugs & Pharmaceuticals F&O

Venmax Drugs & Pharmaceuticals Shareholding Pattern

23.13%
0.15%
65.68%
11.04%

About Venmax Drugs & Pharmaceuticals

  • NSE Symbol
  • VENMAX
  • BSE Symbol
  • 531015
  • Managing Director
  • Mr. N Krishnaiah
  • ISIN
  • INE154G01022

Similar Stocks to Venmax Drugs & Pharmaceuticals

Venmax Drugs & Pharmaceuticals FAQs

Venmax Drugs & Pharmaceuticals share price is ₹13 As on 23 December, 2024 | 04:09

The Market Cap of Venmax Drugs & Pharmaceuticals is ₹7.1 Cr As on 23 December, 2024 | 04:09

The P/E ratio of Venmax Drugs & Pharmaceuticals is -32.3 As on 23 December, 2024 | 04:09

The PB ratio of Venmax Drugs & Pharmaceuticals is -10.9 As on 23 December, 2024 | 04:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23